Coave Therapeutics
PrivateLast Round
Series A
Jan 9, 2025
Total Funding Raised
$117.5M
Momentum Score
25 /100
Company Overview
Coave Therapeutics is a biotechnology company that develops gene therapies for rare ocular and central nervous system (CNS) diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
gene therapyALIGATER platformAAVadeno-associated virusvector engineeringLNPlipid nanoparticletargeted deliveryCNS gene therapyocular gene therapyclinical-stage biotechdrug delivery platformAAV capsid modificationrare diseasesneurodegenerative diseasesbiotech partnershipsRetinitis PigmentosaParkinson's diseaseStargardt's disease
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Coave Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Coave Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jan 9, 2025 | ||||
| Series A | Jan 9, 2025 | ||||
| Series B Extension | Jul 21, 2021 | ||||
| Series B | Nov 8, 2017 | ||||
| Series A | Jul 8, 2016 |
Coave Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Sham Innovation Santé | Series B Extension, Series A, Series B |
| Fund+ | Series B Extension, Series A, Series B |
| Seroba Life Sciences | Series A, Series B Extension |
| Pontifax Venture Capital | Series B |
| Bpifrance | Series A |
| Turenne Groupe | Series B Extension, Series A, Series B |
| Eurazeo Investment Manager | Series B Extension, Series B |
Coave Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Coave Therapeutics's valuation, stock price, and market status.
Firmographic Details
HeadquartersParis
Employee Range46
Year Founded2014
Last FundingJan 9, 2025
